A Nutraceutical Formulation Containing Brown Algae Reduces Hepatic Lipid Accumulation by Modulating Lipid Metabolism and Inflammation in Experimental Models of NAFLD and NASH

A Nutraceutical Formulation Containing Brown Algae Reduces Hepatic Lipid Accumulation by Modulating Lipid Metabolism and Inflammation in Experimental Models of NAFLD and NASH

Recently, some preclinical and clinical studies have demonstrated the ability of brown seaweeds in reducing the risk factors for metabolic syndrome. Here, we analyzed the beneficial effect of a nutraceutical formulation containing a phytocomplex extracted from seaweeds and chromium picolinate in ani...

Full description

Bibliographic Details
Main Authors: Daniela Gabbia, Marco Roverso, Ilaria Zanotto, Martina Colognesi, Katia Sayaf, Samantha Sarcognato, Diletta Arcidiacono, Alice Zaramella, Stefano Realdon, Nicola Ferri, Maria Guido, Francesco Paolo Russo, Sara Bogialli, Maria Carrara, Sara De Martin
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Marine Drugs
Subjects:
NAFLD
NASH
brown seaweed
algal extract
steatosis
<i>Ascophyllum nodosum</i>
Online Access:https://www.mdpi.com/1660-3397/20/9/572

Internet

https://www.mdpi.com/1660-3397/20/9/572

Similar Items